PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K105. A total of 47 filers reported holding PHOENIX BIOTECH ACQUISITION in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,256,000 | – | 124,500 | – | 2.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Beryl Capital Management LLC | 1,230,264 | $12,192,000 | 0.63% |
| CANTOR FITZGERALD, L. P. | 750,000 | $7,433,000 | 0.53% |
| Atalaya Capital Management LP | 450,000 | $4,460,000 | 0.44% |
| Telemetry Investments, L.L.C. | 30,634 | $304,000 | 0.39% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 217,482 | $2,155,000 | 0.30% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,037,794 | $10,285,000 | 0.22% |
| BERKLEY W R CORP | 296,730 | $2,941,000 | 0.16% |
| MMCAP International Inc. SPC | 250,000 | $2,478,000 | 0.15% |
| CVI Holdings, LLC | 195,500 | $1,937,000 | 0.13% |
| CSS LLC/IL | 318,210 | $3,153,000 | 0.11% |